Sintx Technologies (SINT) Expected to Post Quarterly Earnings on Thursday

Sintx Technologies (NASDAQ:SINT) will likely be announcing its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect Sintx Technologies to post earnings of ($0.31) per share and revenue of $1.33 million for the quarter. Investors can find conference call details on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.

Sintx Technologies (NASDAQ:SINT) last released its earnings results on Tuesday, August 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.73) by ($0.02). Sintx Technologies had a negative return on equity of 354.44% and a negative net margin of 848.20%. The company had revenue of $0.45 million during the quarter, compared to analyst estimates of $0.46 million. On average, analysts expect Sintx Technologies to post ($1.67) EPS for the current fiscal year and ($1.17) EPS for the next fiscal year.

Sintx Technologies Stock Performance

Sintx Technologies stock opened at $1.72 on Wednesday. Sintx Technologies has a 1 year low of $1.40 and a 1 year high of $4.46. The firm has a 50 day moving average price of $1.80 and a 200 day moving average price of $2.22.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on SINT. Weiss Ratings reiterated a “sell (e+)” rating on shares of Sintx Technologies in a report on Thursday, October 15th. Ascendiant Capital Markets boosted their price objective on shares of Sintx Technologies from $12.00 to $12.50 and gave the company a “buy” rating in a research note on Thursday, October 1st. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $9.50.

Sintx Technologies Company Profile

SINTX Technologies, Inc (NASDAQ: SINT) is an advanced materials company focused on the development, manufacturing and commercialization of silicon nitride-based ceramics. The company’s technology is designed to combine properties such as biocompatibility, strength, wear resistance and antimicrobial performance for use in medical and other demanding applications.

In its medical business, SINTX develops silicon nitride products for spinal, orthopedic and dental applications, including implant materials, components and coatings.